T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ingredion
INGR
$6.63B
| $192M | 0.04% |
2,558,642
+900,606
| +54% | +$65.5M |
|
452
Kirby Corp
KEX
$7.26B
| $190M | 0.04% |
1,623,418
-24,765
| -2% | -$2.66M |
|
453
Clearwater Paper
CLW
$354M
| $190M | 0.04% |
3,079,110
+854,474
| +38% | +$53.4M |
|
454
Kimco Realty
KIM
$16.4B
| $189M | 0.04% |
8,238,874
-212,941
| -3% | -$4.83M |
|
455
Cintas
CTAS
$80.3B
| $188M | 0.04% |
11,807,104
+279,600
| +2% | +$4.23M |
|
|
FRX
456
DELISTED
FOREST LABORATORIES INC
FRX
| $187M | 0.04% |
1,891,682
-684,400
| -27% | -$63.8M |
|
457
Packaging Corp of America
PKG
$22.9B
| $187M | 0.04% |
2,617,765
-156,696
| -6% | -$10.8M |
|
|
TXNM
458
TXNM Energy Inc
TXNM
$5.91B
| $186M | 0.04% |
6,332,022
-51,424
| -0.8% | -$1.44M |
|
|
ARUN
459
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $185M | 0.04% |
10,564,299
+34,270
| +0.3% | +$646K |
|
|
SCHW
460
Charles Schwab
SCHW
$190B
| $185M | 0.04% |
6,863,482
+52,234
| +0.8% | +$1.37M |
|
461
Glacier Bancorp
GBCI
$6.48B
| $185M | 0.04% |
6,505,726
+56,550
| +0.9% | +$1.52M |
|
|
AIRM
462
DELISTED
Air Methods Corp
AIRM
| $184M | 0.04% |
3,566,580
+34,000
| +1% | +$1.73M |
|
|
STJ
463
DELISTED
St Jude Medical
STJ
| $184M | 0.04% |
2,654,197
-336,230
| -11% | -$21.8M |
|
464
Adtran
ADTN
$658M
| $183M | 0.04% |
8,111,643
+327,050
| +4% | +$7.41M |
|
465
Semtech
SMTC
$12.4B
| $182M | 0.04% |
6,964,510
-97,300
| -1% | -$2.45M |
|
466
Douglas Emmett
DEI
$1.99B
| $182M | 0.04% |
6,445,987
+187,585
| +3% | +$5.22M |
|
|
USG
467
DELISTED
Usg
USG
| $182M | 0.04% |
6,028,450
-10,800
| -0.2% | -$330K |
|
468
EastGroup Properties
EGP
$11B
| $181M | 0.04% |
2,813,298
-10,919
| -0.4% | -$693K |
|
|
BSMX
469
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $179M | 0.04% |
13,455,659
+9,133,829
| +211% | +$116M |
|
470
Trane Technologies
TT
$105B
| $178M | 0.04% |
2,848,523
-251,910
| -8% | -$15M |
|
|
MRO
471
DELISTED
Marathon Oil Corporation
MRO
| $178M | 0.04% |
4,456,471
+720,132
| +19% | +$26.6M |
|
472
Caterpillar
CAT
$393B
| $177M | 0.04% |
1,628,346
-15,620
| -1% | -$1.64M |
|
|
CKH
473
DELISTED
Seacor Holdings Inc.
CKH
| $177M | 0.04% |
2,222,149
+12,119
| +0.5% | +$967K |
|
|
WUBA
474
DELISTED
58.com Inc
WUBA
| $177M | 0.04% |
3,267,615
+2,135,787
| +189% | +$90.6M |
|
475
Altria Group
MO
$109B
| $176M | 0.04% |
4,187,675
-2,219
| -0.1% | -$89.3K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.